LINC00052 inhibits tumor growth, invasion and metastasis by repressing STAT3 in cervical carcinoma

J Lin1, L-L Nong, M-Q Li

  • 1Department of Pathology, Affiliated Hospital of Guilin Medical University, Guilin, China.

Insights

This study on LINC00052 and cervical carcinoma has been withdrawn due to suspected research misconduct. The publisher retracted the article as authors did not verify data originality.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cervical carcinoma is a significant global health concern.
  • Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in cancer.
  • Signal transducer and activator of transcription 3 (STAT3) is a key oncogene in various cancers.

Purpose of the Study:

  • To investigate the role of LINC00052 in cervical carcinoma.
  • To explore the mechanism by which LINC00052 affects tumor growth, invasion, and metastasis.
  • To determine the relationship between LINC00052 and STAT3 signaling in cervical cancer.

Main Methods:

  • The study utilized molecular biology techniques to analyze LINC00052 expression in cervical carcinoma tissues and cell lines.
  • Functional assays were performed to assess the impact of LINC00052 on cell proliferation, migration, and invasion.
  • Western blotting and other methods were employed to investigate the effect of LINC00052 on STAT3 phosphorylation and activation.

Main Results:

  • LINC00052 was found to be downregulated in cervical carcinoma tissues.
  • Overexpression of LINC00052 inhibited tumor growth, invasion, and metastasis in vitro and in vivo.
  • LINC00052 was shown to repress STAT3 signaling by reducing STAT3 phosphorylation.

Conclusions:

  • LINC00052 acts as a tumor suppressor in cervical carcinoma.
  • The inhibitory effect of LINC00052 on tumor progression is mediated through the repression of STAT3 signaling.
  • LINC00052 may serve as a potential therapeutic target for cervical cancer.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.6K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.5K